4 ms·
To understand the medical profession point of view, you need to understand that the "material" used for their research is a rare and precious commodity: humans
by cm2187 11y ago
To understand the medical profession point of view, you need to understand that the "material" used for their research is a rare and precious commodity: humans with a particular condition.
Gathering enough patients to do a study on some particular disease is often difficult and the result of a career long reputation. Doctors usually refer to it as their "recruitment", ie patients addressed to them because they are the reference in this field, something that these "parasite" researchers will get credit for without having to earn it
That's why I believe they are so protective with data.
- tokenadult 11y agoThanks for sharing a professional insider perspective. But wouldn't any other researcher who obtains the data from doctors who recruited the patients have to give credit to the doctors who shared their data? Isn't that a much better professional reputation to have than the reputation of doctors who refuse to share data? Just in the last two weeks, the International Committee of Medical Journal Editors proposed new rules[1] about sharing clinical trial data. Commentators think that kind of data sharing is a very good idea.[2] As a reader of medical research who has heard a lot of "war stories" about the medical research process from family members who have observed that process at first hand, it seems to me that having more eyes on each data set is nearly always a good idea. [1] http://annals.org/article.aspx?articleid=2482115 http://annals.org/article.aspx?articleid=2482115 [2] http://www.statnews.com/pharmalot/2016/01/27/proposal-data-sharing-remarkable-turning-point-says-yales-krumholz/ http://www.statnews.com/pharmalot/2016/01/27/proposal-data-s...
- cm2187 11y agoI am not a doctor. But I come from a family of doctors. Patient privacy aside, I do agree with you and with the critics of the New England. Science is about reproducable experiments, and in medecine, because of the constraints on the "research material", most studies are on the edges of statistical significance, and with professionals that aren't trained statisticians. The only mitigant to that is data sharing.
- riahi 11y agoSharing the data doesn't get you promoted in academia. Writing papers where you repeatedly mine the hand-crafted-over-20-years dataset does. If you give your dataset away for free, you're destroying your only way to advance in academic medicine. What we need are alternative funding models for academic medicine. With all the negative press and ethical issues from pharma funding the studies, and the NIH cutting their funding, publish or perish is even more important if you want a sliver of a chance to get some of the remaining grant money.
- jensen123 11y agoSo I guess the concern "that data sharing would require them to commit scarce resources with little direct benefit" is just a pretext then. Obviously, just putting some data up on a website is cheap.
- riahi 11y agoIt is cheap, but how do you measure that? There's no impact factor or associated journal publication. Since simply providing the data can't be measured for tenure or fit into a line item on a CV, academia as a whole assigns it zero value. This then means that simply sharing data is a huge net negative given the high costs of acquiring it.
- phloxicon 11y ago"But wouldn't any other researcher who obtains the data from doctors who recruited the patients have to give credit to the doctors who shared their data?" In academia, it's better to be the primary author of a paper. More primary author publications makes it easier to get funding, keep your job and advance your career. If you share the data that you might have spent a lot of time and money collecting, you will either gain a citation or a non-primary author position. This is worse for your career. I don't like the system. Most academics would prefer to share to have their work verified or even to see what others might find but the incentives are to keep it private so that you can squeeze as many primary papers (or papers from your research group) as possible out of a data set before sharing the paper.
- carbocation 11y agoThe backlash is from physician scientists (among others), though. It's not really "medical" vs "non-medical" so much as it is "closed" vs "open", with physician scientists on both sides.
- etangent 11y agoYes, medical data is expensive and hard to obtain. But that's not (at least in the direct sense) the reason why so many medical researchers want to keep the data to themselves. The actual reason is that there is a whole cottage industry based on trading access to data for paper co-authorship. If the researchers were to share their data openly, the person who comes after them would be able to just cite the data without having to beg the researcher for access while promising him/her a sweet co-authorship spot in return.
- _delirium 11y agoIn CS (which is admittedly quite different), one counterbalancing incentive is that citations are at least as important as coauthorships in recent years, and releasing data is one relatively easy way to get a boost in citations. If you just release results, then people only cite your paper if they're doing particularly related work. But if you also release an accompanying dataset, all sorts of random people will cite this paper as the source of the data (if the data is interesting, anyway), even if they don't care about the paper itself.
- bachmeier 11y ago> The actual reason is that there is a whole cottage industry based on trading access to data for paper co-authorship. Is that a problem? That's the way it should be. Requiring that the data be shared does not rule out a requirement that the person that creates the dataset is automatically a coauthor.
- dikdik 11y agoYou're probably very close to correct on this, but it doesn't make it right nor the moral thing to do. Also, a lot of patients end up exploited by docs and companies who sell these very expensive samples taken from patients with rare diseases. The patients don't benefit from that, but the docs and medical institutions do. So while we try to "protect" medical research for the sake of doctors, they are not only using their patients for profit but they are hindering medical research in the name of their profits. And yes, I worked for a medical lab where I helped identify and sell patient blood and tumor samples with rare forms of blood cancers. I'm not necessarily against selling patient samples where the patient doesn't benefit, but blindly protecting doctors' claims to research data doesn't tell the whole story.
- danieltillett 11y agoJust to nitpick it is more important to be the corresponding author. While there is often a fight over who gets to be the primary author (i.e. the junior person who did all the work), it is nothing compared to the fights that go on between the PIs as to who will be the corresponding author. Grants and millions of dollars are at stake in these fights.